ASCO Presentation Addresses Use of Avatar Mice to Assess Genomics-based Personalized Cancer Treatment Schemes | GenomeWeb

CHICAGO (GenomeWeb News) – A presentation at the annual American Society of Clinical Oncology meeting this weekend addressed the feasibility — and remaining challenges — of using so-called avatar mouse models to assess treatments targeting apparent driver mutations gleaned from cancer genome sequence data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.